Are you a high-potential MedTech innovator looking to accelerate your journey from concept to investment-ready venture? The MedTech Venture Builder is a unique 12-month structured programme designed to fast-track the commercial translation of groundbreaking medical technologies.
Now in its second year, the MedTech Venture Builder provides a comprehensive framework to de-risk your company, including regulatory planning, clinical evidence roadmaps, stakeholder mapping, and hands-on expert support—all within a fit-for-purpose Quality Management System (QMS).
Join us for an in-person Application Info Session on Wednesday 26 March to gain a deeper understanding of how the MedTech Venture Builder programme can support your venture.
Through expert mentorship, hands-on guidance, and real-world industry connections, the MedTech Venture Builder, delivered by LIHE, helps innovators turn promising ideas into market-ready ventures.
Thomas Vargoczky, CEO of Pryfiber, a spinout from Queen Mary University of London, and a member of our ongoing MVB cohort shares his experience of the programme:
The MedTech Venture Builder is funded by Research England and is a collaborative effort between London’s leading academic institutions, King's College London (lead), Queen Mary University of London, and City St George’s, University of London.
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.